Difficulty: Medium
Average Score: 94%
Testbank
An oncology nurse is contributing to the care of a patient who has failed to respond appreciably to conventional cancer treatments. As a result, the care team is considering the possible use of biologic response modifiers (BRFs). The nurse should know that these achieve a therapeutic effect by what means?
Correct answer
D
Rationale
D: Altering the immunologic relationship between the tumor and the patient.
This option is correct because biologic response modifiers (BRFs) work by enhancing the body’s immune response to cancer, effectively changing how the immune system interacts with the tumor, potentially leading to improved tumor recognition and destruction.
A: Promoting the synthesis and release of leukocytes. This option fails because while leukocyte activity is important, BRFs specifically alter the immune response rather than just increasing leukocyte production without targeting the tumor.
B: Focusing the patients immune system exclusively on the tumor. This option is inaccurate as BRFs do not exclusively target tumors; they enhance the overall immune response, which can involve multiple pathways and immune components.
C: Potentiating the effects of chemotherapeutic agents and radiation therapy. This option is misleading because BRFs primarily modify immune responses rather than directly enhancing the effects of chemotherapy or radiation, which are separate treatment modalities.
This option is correct because biologic response modifiers (BRFs) work by enhancing the body’s immune response to cancer, effectively changing how the immune system interacts with the tumor, potentially leading to improved tumor recognition and destruction.
A: Promoting the synthesis and release of leukocytes. This option fails because while leukocyte activity is important, BRFs specifically alter the immune response rather than just increasing leukocyte production without targeting the tumor.
B: Focusing the patients immune system exclusively on the tumor. This option is inaccurate as BRFs do not exclusively target tumors; they enhance the overall immune response, which can involve multiple pathways and immune components.
C: Potentiating the effects of chemotherapeutic agents and radiation therapy. This option is misleading because BRFs primarily modify immune responses rather than directly enhancing the effects of chemotherapy or radiation, which are separate treatment modalities.